Effects of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Implication of circulating cancer cells by detection of α-fetoprotein mRNA

Experimental and Therapeutic Medicine

Volumn 1, Issue 3, 2010, Pages 485-491

  Murakami, Masahiro ^a   Nagano, Hiroaki ^a   Kobayashi, Shogo ^a   Wada, Hiroshi ^a   Nakamura, Masato ^a,b   Marubashi, Shigeru ^a   Eguchi, Hidetoshi ^a   Takeda, Yutaka ^a   Tanemura, Masahiro ^a   Umeshita, Koji ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Specified Medical Corporation Jisenkai Aizawa Hospital   (Japan)

Author keywords

fetoprotein messenger RNA; Circulating cancer cells; Hepatectomy; Hepatocellular carcinoma; Preoperative transarterial chemoembolization

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN; PREDICTOR VARIABLE; PREOPERATIVE TREATMENT; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR NECROSIS; TUMOR VOLUME;

EID: 77956221596     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000076     Document Type: Article

References (34)

1. Poon RT, Fan ST, Tsang FH, Wong J: Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 235: 466-486, 2002.
2. Witzigmann H, Geissler F, Benedix F, et al: Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNAin patients with hepatocellular carcinoma. Surgery 131: 34-43, 2002.
3. Lemoine A, Le Bricon T, Salvucci M, et al: Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNAin humans during liver surgery. Ann Surg 226: 43-50, 1997.
4. Kamiyama T, Takahashi M, Nakagawa T, et al: AFPmRNAdetected in bone marrow by real-time quantitative RT-PCRanalysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg 244: 451-463, 2006.
5. Morimoto O, Nagano H, Miyamoto A, et al: Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNAlevels in peripheral blood. Surg Today 35: 1033-1041, 2005.
6. Miyamoto A, Nagano H, Sakon M, et al: Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR. Int JOncol 18: 527-532, 2001.
7. Marubashi S, Dono K, Sugita Y, et al: Alpha-fetoprotein mRNAdetection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc 38: 3640-3642, 2006.
8. Marubashi S, Dono K, Nagano H, et al: Detection of AFPmRNA-expressing cells in the peripheral blood for prediction of HCCrecurrence after living donor liver transplantation. Transpl Int 20: 576-582, 2007.
9. Peng BG, He Q, Li JPand Zhou F: Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 198: 313-318, 2009.
10. Sugo H, Futagawa S, Beppu T, Fukasawa Mand Kojima K: Role of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 27: 1295-1299, 2003.
11. Zhong C, Guo RP, Li JQ, et al: Arandomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 135: 1437-1445, 2009.
12. Lu CD, Peng SY, Jiang XC, Chiba Yand Tanigawa N: Pre-operative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg 23: 293-300, 1999.
13. Di Carlo V, Ferrari G, Castoldi R, et al: Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 45: 1950-1954, 1998.
14. Majno PE, Adam R, Bismuth H, et al: Influence of pre-operative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226: 688-703, 1997.
15. Harada T, Matsuo K, Inoue T, Tamesue S and Nakamura H: Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 224: 4-9, 1996.
16. Gerunda GE, Neri D, Merenda R, et al: Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl 6: 619-626, 2000.
17. Imaoka S, Sasaki Y, Shibata T, et al: Apre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother Pharmacol 23: S126-S128, 1989.
18. Adachi E, Matsumata T, Nishizaki T, Hashimoto H, Tsuneyoshi M and Sugimachi K: Effects of pre-operative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 72: 3593-3598, 1993.
19. Zhang Z, Liu Q, He J, Yang J, Yang G and Wu M: The effect of pre-operative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 89: 2606-2612, 2000.
20. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ and P'Eng FK: Pre-operative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82: 122-126, 1995.
21. Yamasaki S, Hasegawa H, Kinoshita H, et al: Aprospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87: 206-211, 1996.
22. Zhou WP, Lai EC, Li AJ, et al: Aprospective, randomized, controlled trial of pre-operative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249: 195-202, 2009.
23. Monden M, Okamura J, Sakon M, et al: Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas. Cancer Chemother Pharmacol 23: S90-S95, 1989.
24. Paye F, Jagot P, Vilgrain V, Farges O, Borie D and Belghiti J: Pre-operative chemoembolization of hepatocellular carcinoma: a comparative study. Arch Surg 133: 767-772, 1998.
25. Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S and Mori M: Pre-operative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 32: 773-779, 2006.
26. Choi GH, Kim DH, Kang CM, et al: Is pre-operative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? World J Surg 31: 2370-2377, 2007.
27. Nagasue N, Galizia G, Kohno H, et al: Adverse effects of pre-operative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 106: 81-86, 1989.
28. Uchida M, Kohno H, Kubota H, et al: Role of pre-operative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 20: 326-331, 1996.
29. Lee KT, Lu YW, Wang SN, et al: The effect of pre-operative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. J Surg Oncol 99: 343-350, 2009.
30. Seldinger SI: Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol 39: 368-376, 1953.
31. Dindo D, Demartines N and Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213, 2004.
32. Gross-Goupil M, Saffroy R, Azoulay D, et al: Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Ann Surg 238: 241-248, 2003.
33. Jang MK, Lee HC, Kim IS, et al: Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization. J Gastroenterol Hepatol 19: 1074-1080, 2004.
34. Herber S, Biesterfeld S, Franz U, et al: Correlation of multislice CTand histomorphology in HCCfollowing TACE: predictors of outcome. Cardiovasc Intervent Radiol 31: 768-777, 2008.